Tue, Sep 16, 2014, 9:46 AM EDT - U.S. Markets close in 6 hrs 14 mins


% | $
Quotes you view appear here for quick access.

BioTime, Inc. Message Board

  • drwestclone drwestclone Dec 15, 2013 5:56 PM Flag

    CANCER ALERT-Here's a look at our cancer IP

    As previously announced Biotime PanC-DX Breast cancer product will be a blood diagnostic test to be released first in the EU then in the US(after 6 mo evaluation) mid 2014. Lung and Bladder coming soon after.

    Here are three key BTX patents protecting their cutting edge diagnostics products:
    -Elevated expression of cancer/testis antigen FSIP1 in ER-positive breast tumors.
    -Defining cell-matrix combination products in the era of pluripotency.
    -Identification of human embryonic progenitor cell targeting peptides using phage display.
    -COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature.
    -Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.570.00(0.00%)9:35 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.